Benefits, Challenges and Potential Strategies of Open Source Health Economic Models

Abstract

A common criticism of the pharmaceutical industry is that it fails to achieve transparency [ 1 , 2 ]. To allay concerns, the industry needs to collaborate openly with stakeholders to make medicines widely available and affordable—this will mean companies need to address some of their practices [ 1 , 3 , 4 ]. We suggest that an important practice to address is the presentation of health economic models.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 64 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.